The 2026 Medicare Advantage Shake-Up: What Retiree Plan Sponsors Need to Know Now
The Medicare Advantage market is undergoing one of its most significant resets in a decade. For unions, municipalities, and large employers sponsoring retiree healthcare, the window to act is now — before renewal season narrows your options.
Key Question: Is your retiree plan still in the right Medicare Advantage arrangement — with the right carrier, the right structure, and the right partner to navigate what’s coming?
The Market Is Shifting in Ways Plan Sponsors Can’t Ignore
For years, Medicare Advantage enrollment climbed steadily, offering employers and unions a reliable, cost-effective vehicle for retiree coverage. That era of stability is over — at least temporarily.
For 2026, CMS projects total Medicare Advantage enrollment will drop from roughly 34.9 million to 34.0 million — the first projected net decline in years. Several major carriers are pulling back, restricting service areas, or exiting markets entirely as compressed margins make some geographies and populations unprofitable.
Consider what’s happening on the ground:
• UnitedHealth — the largest Medicare Advantage administrator in the country — has announced it will stop offering MA plans in 109 counties, affecting hundreds of thousands of beneficiaries.
• Humana and Aetna are reportedly scaling back in certain regions, particularly rural and lower-density markets.
• Plan consolidation is reducing the total number of available MAPD plans nationally from 5,633 in 2025 to approximately 5,600 in 2026.
• A JAMA study found that approximately 2.9 million Medicare Advantage beneficiaries — about 10% — have needed to find other coverage this year due to plan withdrawals or structural changes.
For retiree plan sponsors, these carrier-level shifts translate directly into potential disruption: mid-year rate changes, network narrowing, benefit erosion, or in some cases, losing access to a plan entirely.
What’s Driving the Disruption: Key 2026 Policy Changes
The instability in the MA market isn’t random. It’s being driven by a confluence of regulatory and funding changes that are forcing carriers to reprice and restructure their offerings:
Part D Redesign Under the Inflation Reduction Act
The Inflation Reduction Act continues to reshape how prescription drug costs flow through MAPD plans. For 2026, the Part D out-of-pocket cap reaches $2,100 — up from $2,000 — and the maximum Part D deductible rises to $615. Insulin remains capped at $35/month with no deductible applied. These structural changes affect carrier pricing models and, in turn, the rates plan sponsors pay.
New Restrictions on Supplemental Benefits
Starting in 2026, CMS has codified significant new restrictions on the Special Supplemental Benefits for the Chronically Ill (SSBCI) category. Plans must now document qualifying chronic conditions more rigorously, adhere to standardized benefit categories, and cap spending on non-health-related supplemental extras. The result: fewer bells and whistles in some plans, and less flexibility in benefit design.
Prior Authorization Rule Tightening
CMS is restricting plans’ ability to reverse previously approved inpatient admissions — a major change that closes appeals loopholes that have adversely affected both providers and enrollees. While this is a positive development for member protection, it creates additional administrative complexity for carriers and may influence plan pricing.
Provider Directory Transparency Mandate
A new CMS requirement mandates that MA plans submit current provider directory data directly to CMS for publication in the Medicare Plan Finder — and must update that data within 30 days of any change. For plan sponsors, this is a welcome transparency improvement, but it also signals heightened regulatory scrutiny across the board.
CMS Payment Rate Adjustments
CMS approved an average 5.06% payment rate increase to MA plans — roughly $25 billion system-wide — for 2026. However, carriers operating in markets with higher-than-average utilization or adverse risk pools are not all benefiting equally, which is contributing to selective market exits.
The Real Risk for Retiree Plan Sponsors
If your organization hasn’t conducted an independent market check recently, you may be operating on carrier-supplied projections that don’t reflect the full range of options available to you.
Many plan sponsors renew their Medicare Advantage arrangements on autopilot. The carrier presents projections, the contract rolls over, and the plan sponsor assumes they’re getting competitive terms. In a stable market, that approach is manageable. In this market, it’s a liability.
A proper market check evaluates:
• Whether your current MAPD rates are competitive given current carrier pricing and carrier-specific risk adjustments
• How your plan design aligns with the new CMS funding models and supplemental benefit restrictions
• Whether network access and member experience metrics are improving or deteriorating
• How Part D redesign changes will affect your retirees’ out-of-pocket costs and your plan’s cost structure
• Whether a different carrier, or a different plan structure entirely, would better serve your population
The Strategic Case for MA + PDP Decoupling
One emerging strategy worth evaluating is the decoupling of Medicare Advantage medical coverage from the Part D prescription drug benefit.
Traditionally, most retiree plans use bundled MAPD products — a single carrier administers both the medical and pharmacy benefits. But as Part D cost structures shift under the IRA, some plan sponsors are exploring whether separating these components could deliver:
• Greater pricing transparency on both the medical and pharmacy sides
• More aggressive PBM negotiations independent of carrier relationships
• Flexibility to optimize plan design for your specific retiree population’s drug utilization patterns
• Meaningful cost control without reducing retiree benefits
Decoupling isn’t the right answer for every group, and it adds administrative complexity. But for organizations with large retiree populations and significant prescription drug spend, the analysis is worth conducting — especially before the 2027 plan year when additional IRA-negotiated drug prices take effect.
Why SHN Approaches This Differently
Solidarity Health Network was founded in 1989 by AFL-CIO labor leaders who understood that retiree healthcare isn’t just an insurance product — it’s a contractual promise to the people who built their careers and communities.
As a union-based Third-Party Administrator staffed by Communications Workers of America Local 4340 members, SHN operates without the carrier relationships that can create conflicts of interest in traditional brokerage models.
We help plan sponsors evaluate the entire Medicare Advantage marketplace independently.
Our work with retiree populations includes:
• Independent rate and benefit analysis across carriers and plan structures
• MAPD market checks benchmarked against current CMS funding models
• Evaluation of MA + PDP decoupling opportunities for qualified groups
• Ongoing compliance monitoring and plan performance tracking
• Support for Taft-Hartley, union, and public-sector retiree plans
Email aglorioso@shninc.org for additional information.
The Timeline Is Tighter Than It Looks
Open enrollment for 2026 Medicare Advantage plans closed December 7, 2025. The Medicare Advantage Open Enrollment period runs January 1 through March 31, 2026 — giving plan sponsors a narrow window to make mid-year strategic adjustments for current beneficiaries.
More importantly, planning for the 2027 plan year should begin now. Organizations that start evaluating their options early will have the greatest ability to:
• Control costs before renewal season compresses negotiating leverage
• Protect retiree benefits against carrier-driven erosion
• Avoid rushed decisions that lock in suboptimal arrangements
• Position the plan ahead of additional Part D changes taking effect in 2027
Waiting until the fall enrollment season means fewer options — and higher costs.
A Promise Worth Protecting
For unions, municipalities, and large employers, retiree healthcare is more than a line item. It’s a promise made across the bargaining table, and in many cases, a contractual obligation.
The Medicare Advantage market is being reset. Carriers are repricing. Networks are narrowing. Plans are exiting. The plan sponsors who navigate this well will be the ones who sought independent expertise before renewal season — not during it.
Now is the time to take a closer look.
Ready for an Independent MAPD Market Check?
Contact SHN Inc. to learn how we help unions, municipalities, and employers evaluate their retiree healthcare options independently. • www.shninc.org
Solidarity Health Network, Inc. (SHN) | Founded 1989 | SOC 2 Type II Certified | HIPAA Compliant | 340,000+ lives supported | www.shninc.org